Abcam ^ABCM

CellVoyant is an AI-first biotechnology company focused on curing chronic diseases through the development of stem cell therapies. Their services aim to accelerate the development of these therapies, making the process faster and more cost-effective. Using AI-first live cell imaging, CellVoyant's technology predicts and optimizes stem cell differentiation, allowing for the controllable manufacturing of any cell and tissue in the body at scale. The organization operates at the intersection of cell biology, computer vision, engineering, and machine learning, with the goal of bringing next-generation science from research to the real world. CellVoyant is supported by top venture capital firms and has a strong backing from investors in AI pioneers and self-driving technology.